Publications by authors named "J Haraschak"

Article Synopsis
  • The study focuses on evaluating the clinical aspects and treatment outcomes of dogs diagnosed with blastomycosis, specifically those treated with high-flow nasal oxygen therapy (HFNOT).
  • A total of 19 dogs were observed, with varying transitions from traditional oxygen therapy to HFNOT; only one dog survived to be discharged, while the majority either died or were euthanized due to the disease's progression.
  • The findings suggest that the prognosis for dogs requiring advanced oxygen therapy for severe blastomycosis is poor, marking this as the first documented use of HFNOT for such cases in dogs.
View Article and Find Full Text PDF

Objective: To describe the presentation, management, and postmortem examination findings in a dog with confirmed lisdexamfetamine dimesylate (LDX) toxicosis.

Case Summary: A 3-year-old female neutered mixed breed dog initially presented with neurological signs suspected to be secondary to LDX toxicosis. The dog was treated as typical for amphetamine toxicoses but developed severe respiratory and cardiovascular signs throughout their hospitalization.

View Article and Find Full Text PDF

Objective: To describe the successful management of 2 cats following ingestion of minoxidil 5%.

Series Summary: Two 2-year-old neutered male Savannah cats were presented following suspected minoxidil 5% ingestion. Both cats developed significant myocardial injury, and clinical signs were consistent with congestive heart failure, supported by cardiac troponin I concentrations, echocardiogram, and thoracic radiographs.

View Article and Find Full Text PDF

Objective: Evaluate the clinical utility of the systemic inflammatory response syndrome (SIRS) criteria in dogs and cats presenting to an emergency room (ER).

Design: Prospective and retrospective observational study, conducted from November 2019 to February 2020.

Setting: Small animal university teaching hospital.

View Article and Find Full Text PDF

A 5-month-old male intact Great Pyrenees was presented for an acute onset of severe neurologic signs (stupor, absent menace, intermittent head turn to the left). The patient's history included possible naproxen ingestion with a maximum ingested dose of 59 mg/kg, exceeding the reported dose of >50 mg/kg known to cause neurologic signs. Blood sampling for baseline bloodwork was performed, and intravenous lipid emulsion (ILE) was subsequently administered, for treatment of the suspected toxicosis.

View Article and Find Full Text PDF